Genmab — August 2020
-
Så fik jo alligevel en lille opjustering:
-
Genmab får 30 mio. dollars og opjusterer forventningerne
Den danske medicinalvirksomhed modtager 30 mio. dollars i kompensation for kræftmedicin.
Finans (finans.dk)
-
Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX
(daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma -
@Pensionisten - Det må være fredagsvitsen.
-
GRIFFIN trial published in Blood https://twitter.com/slentzsch/status/1296600541758476291?s=21
-
Comment from Dr. Suzanne Lentzsch „my new SOC“
-
God morgen.
-
God morgen
-
twitter: Jeffrey Cranmer
@jeff_cranmer
Pandemic could give a leg up to #MultipleSclerosis newcomer Kesimpta ofatumumab / At an annual WAC of $83K, #Kesimpta is more $$$ than a 300 mg dose of Ocrevus from
@genentech
($16K-_>$65K/yr; but Bulto noted that the auto-injector avoids the added costs of infusions. https://twitter.com/jeff_cranmer/status/1296595805030117376
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind